Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Serkan DEĞİRMENCİOĞLU"'
Autor:
Melek ÖZDEMİR, Gamze GÖKOZ DOĞU, Burcu YAPAR TAŞKÖYLÜ, Atike Gökçen DEMİRAY, Burçin ÇAKAN DEMİREL, Tolga DOĞAN, Taliha GÜÇLÜ KANTAR, Arzu YAREN, Serkan DEĞİRMENCİOĞLU, Semra TAŞ, Bedriye AÇIKGÖZ YILDIZ, Gamze Serin ÖZEL
Publikováno v:
Namık Kemal Tıp Dergisi, Vol 12, Iss 3, Pp 155-162 (2024)
Aim: According to the information obtained from the World Health Organization database, the incidence of hepatocellular carcinoma (HCC) in Turkey increased by 17.78% between the years of 2018 and 2020. In this study, we investigated the prognostic va
Externí odkaz:
https://doaj.org/article/991712c2587e49699349f14a0eeb8977
Autor:
Atike Gökçen Demiray, Aydın Demiray, Arzu Yaren, Burcu Taşköylü, Gamze Gököz Doğu, Serkan Değirmencioğlu, Umut Çakıroğlu, Nail Özhan, Canan Karan, Burçin Çakan Demirel, Tolga Doğan, Melek Özdemir
Publikováno v:
The Turkish Journal of Gastroenterology, Vol 33, Iss 8, Pp 696-703 (2022)
Externí odkaz:
https://doaj.org/article/161a9eb498124b999615efef94d858c9
Autor:
Şule Gökşin, Serkan Değirmencioğlu
Publikováno v:
Turkderm Turkish Archives of Dermatology and Venereology, Vol 56, Iss 3, Pp 135-137 (2022)
Nivolumab is an immunotherapy drug developed to increase the ability of the immune system to target and kill cancer cells and is a human immunoglobulin G4 monoclonal antibody blocking programmed cell death-1. Nivolumab is a checkpoint inhibitor that
Externí odkaz:
https://doaj.org/article/ec7f4550be1c478b85984aaa1a9744c6
Autor:
Ali Alkan, Zeynep Gülsüm Güç, Mustafa Gürbüz, Güliz Özgün, Serkan Değirmencioğlu, Mutlu Doğan, Tuğba Akın Telli, Özge Keskin, Çağatay Arslan, Burak Bilgin, Sema Sezgin Göksu, Hacer Demir, Elif Berna Köksoy, Osman Köstek, İsmail Ertürk, Teoman Şakalar, Arzu Yaşar, Görkem Türkkan, Büşra Kasım, Aziz Karaoğlu, Berna Çakmak Öksüzoğlu, Fulden Yumuk, Mehmet Ali Şendur, Hasan Şenol Coşkun, İrfan Çiçin, Nuri Karadurmuş, Özgür Tanrıverdi, Hakan Akbulut, Yüksel Ürün
Publikováno v:
Journal of Men's Health, Vol 17, Iss 4, Pp 128-134 (2021)
Introduction: The efficacy and tolerability of Enzalutamide and Abiraterone Acetate have been reported in elderly patients with metastatic castration resistant prostate cancer (mCRPC). However, there is no randomized study directly comparing antitumo
Externí odkaz:
https://doaj.org/article/b4dace8ad4e24ea2ba76c16fee1bb85f
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 11 (2017)
Introduction: Cancer cachexia is one of the most frequent effects of malignancy, is often associated with poor prognosis, and may account for up to 20% of cancer deaths. The aim of our study was to evaluate the relationship of cancer cachexia and ser
Externí odkaz:
https://doaj.org/article/96803f3ad43445fa829ad858ac57efe1
Autor:
Atike Gökçen Demiray, Arzu Yaren, Uğur Sungurtekin, Papatya Bahar Baltalarlı, Neşe Demirkan, Duygu Herek, Burcu Yapar Taşköylü, Gamze Gököz Doğu, Serkan Değirmencioğlu, Utku Özgen, Halil Sağınç, Umut Çakıroğlu, Nail Özhan, Canan Karan, Burçin Çakan Demirel, Tolga Doğan, Melek Özdemir
Publikováno v:
Journal of Oncology. 2022:1-8
Aim. The current standard treatment of locally advanced rectal carcinoma is total mesorectal excision and postoperative adjuvant chemotherapy after neoadjuvant concurrent chemoradiotherapy (NCRT). Many studies have shown that pathological complete re
Autor:
Tolga DOĞAN, Arzu YAREN, Atike Gökçen DEMİRAY, Burcu YAPAR TAŞKÖYLÜ, Burçin ÇAKAN DEMİREL, Melek ÖZDEMİR, Taliha GÜÇLÜ KANTAR, Serkan DEĞİRMENCİOĞLU, Gamze GOKOZ DOGU
Publikováno v:
Pamukkale Medical Journal.
Purpose:We evaluated the effect of pre-treatment inflammation response markers on overall survival (OS) and progression-free survival (PFS) in patients with locally advanced unresectable and metastatic gastric cancer. Material and Method:Patients wit
Autor:
Atike Gökçen Demiray, Arzu Yaren, Burcu Yapar Taşköylü, Serkan Değirmencioğlu, Gamze Gököz Doğu
Publikováno v:
Dicle Medical Journal, Vol 48, Iss 1, Pp 163-170 (2021)
Objective: Glioblastoma Multiforme (GBM) is the most common primary malignant brain tumor in adults. Optimal treatment is adjuvant concomitant chemoradiotherapy following the widest possible surgical resection (maximum safe resection) followed by adj
Autor:
Burcu Yapar Taskoylu, Atike Gökçen Demiray, Serkan Değirmencioğlu, Gamze Gököz Doğu, Arzu Yaren
Publikováno v:
Volume: 48, Issue: 1 163-170
Dicle Tıp Dergisi
Dicle Tıp Dergisi
Amaç: Glioblastoma Multiforme (GBM) erişkinlerde en sık görülen primer malign beyin tümörüdür. Optimal tedavisi, mümkün olan en geniş cerrahi rezeksiyon (maksimum güvenli rezeksiyon) sonrasında adjuvan eşzamanlı kemoradyoterapi ve ard
Autor:
Arzu Yaren, Ferda Bir, Serkan Değirmencioğlu, Ahmet Ergin, Canan Karan, Gamze Gököz Doğu, Burcu Yapar Taskoylu, Aydın Demiray, Atike Gökçen Demiray, Hakan Akca, Umut Çakiroğlu, Nail Özhan
Publikováno v:
Journal of Oncological Sciences. 6:147-152
Objective:Apoptosis plays a critical role in carcinogenesis. Intracellular proteases known as caspase-9 directly or indirectly playroles inactivating apoptosis. In this study, we aimed to investigate the effect of caspase-9 level in lung skuamous can